DSM Partners with Merck to Bring Metafolin Folate to Market
DSM announces its partnership with Merck to distribute and market its L-MTHF Metafolin folate to the dietary supplement and food industries.
Metafolin folate is the biologically active form of the naturally-occurring predominant form of folate. Merck says it is well absorbed and its bioavailability is not affected by metabolic variations that prevent a large proportion of the population from efficiently converting traditional folic acid into the metabolically active form needed to deliver a wide range of health benefits.
Folates are water-soluble B-vitamins that offer a number of health benefits supported by European Food Safety Authority (EFSA) approved health claims. These include Article 13.1 health claims relating to the role folates play in contributing to normal blood formation, cell division, maternal tissue growth during pregnancy, psychological functions, metabolism of the immune system, amino acid synthesis and can contribute to the reduction of tiredness and fatigue.
While natural folates are found in various food products, they can be unstable and easily damaged during processing. Folic acid has therefore been used in supplements and to fortify foods as it is more stable compared to natural folates. However, ingested folic acid must go through a series of enzymatic processes before it becomes a biologically active and useful form for human health. These processes can be hindered by genetic variations, resulting in difficulties converting folic acid into the active folate form.
Researchers from Merck say that Metafolin (L-5-methyltetrahydrofolic acid, calcium salt) is the pure, stable crystalline form of the naturally-occurring predominant form of folate manufactured by Merck and brought to market by DSM. A readily bio available folate vitamer, Metafolin is easily absorbed by the human body to ensure adequate uptake of the vital vitamin. Suitable for use in supplements, beverages and fortified foods, Metafolin can help to improve the efficacy of folate uptake in all consumers.
“Merck actively seeks strategic partnerships to complement and enhance our portfolio. Working with DSM to distribute our innovative L-MTHF product allows us to widen our target markets and bring this innovative product to a larger number of people than ever before,” comments Dr. Rudolf Moser, managing director at Merck & Cie, Switzerland.
Jacob Bauly, global marketing manager, DSM, adds, “We’re delighted to be working with Merck to bring Metafolin to the market. Folates are often associated with maternal health, however this vitamin plays a number of vital roles in the body. Metafolin directly enters the metabolic process and could be an effective and safe alternative to folic acid supplementation. Metafolin allows these people to consume folates and take advantage of the many health benefits they can bring without having to change their lifestyle.”